Ipilimumab may restore antitumor immunity after relapse from HSCTJuly 13, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
SU2C announces researcher-industry collaboration on immunotherapyJuly 13, 2016Genitourinary CancerHead & Neck/Thyroid CancersMelanomaImmuno-oncologyRenal Cell Carcinoma
Three-drug regimen boosts progression-free survival in patients with relapsed CLL and adverse prognostic featuresJuly 13, 2016Leukemia, Myelodysplasia, Transplantation
Incidence of HPV-associated cancers on the riseJuly 12, 2016PediatricsGynecologic CancerPreventive Care